These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 8909334)

  • 1. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Weissenburger JE; Fulton CL; Fairchild CJ; Roffwarg HP
    Biol Psychiatry; 1997 May; 41(9):915-28. PubMed ID: 9110097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
    Kumar A; Alcser K; Grunhaus L; Greden JF
    Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dexamethasone suppression test in adolescent outpatients with major depressive disorder.
    Birmaher B; Dahl RE; Ryan ND; Rabinovich H; Ambrosini P; al-Shabbout M; Novacenko H; Nelson B; Puig-Antich J
    Am J Psychiatry; 1992 Aug; 149(8):1040-5. PubMed ID: 1636803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DST studies in psychotic depression: a meta-analysis.
    Nelson JC; Davis JM
    Am J Psychiatry; 1997 Nov; 154(11):1497-503. PubMed ID: 9356556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of biologic markers in a general hospital affective disorders program.
    Lieber AL; Newbury N
    J Clin Psychiatry; 1985 Jun; 46(6):217-21. PubMed ID: 3922959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four definitions of endogenous depression and the dexamethasone suppression test.
    Zimmerman M; Coryell W; Pfohl B; Stangl D
    J Affect Disord; 1985; 8(1):37-45. PubMed ID: 3156910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of endogenous depression. Comparison of clinical, research and neuroendocrine criteria.
    Carroll BJ; Feinberg M; Greden JF; Haskett RF; James NM; Steiner M; Tarika J
    J Affect Disord; 1980 Sep; 2(3):177-94. PubMed ID: 6210723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in- and outpatients.
    Syvälahti E
    Acta Psychiatr Scand; 1985 Feb; 71(2):105-10. PubMed ID: 3976406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological 'markers' for endogenous depression. Effect of age, severity of illness, weight loss, and polarity.
    Feinberg M; Carroll BJ
    Arch Gen Psychiatry; 1984 Nov; 41(11):1080-5. PubMed ID: 6497570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
    Rush AJ; Schlesser MA; Roffwarg HP; Giles DE; Orsulak PJ; Fairchild C
    J Clin Psychiatry; 1983 Aug; 44(8 Pt 2):23-9. PubMed ID: 6409892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopathological correlates of plasma cortisol after dexamethasone suppression: a polydiagnostic approach.
    Philipp M; Maier W; Holsboer F
    Psychoneuroendocrinology; 1986; 11(4):499-507. PubMed ID: 3562743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep EEG and dexamethasone suppression test findings in outpatients with unipolar major depressive disorders.
    Rush AJ; Giles DE; Roffwarg HP; Parker CR
    Biol Psychiatry; 1982 Mar; 17(3):327-41. PubMed ID: 7082700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test with mildly to moderately depressed outpatients.
    Rabkin JG; Quitkin FM; Stewart JW; McGrath PJ; Puig-Antich J
    Am J Psychiatry; 1983 Jul; 140(7):926-7. PubMed ID: 6859319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysomnographic findings and dexamethasone nonsuppression in unipolar depression: a replication and extension.
    Giles DE; Schlesser MA; Rush AJ; Orsulak PJ; Fulton CL; Roffwarg HP
    Biol Psychiatry; 1987 Jul; 22(7):872-82. PubMed ID: 3607114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression test and urinary MHPG X SO4 determination in depressive disorders.
    Zhou DF; Shen YC; Shu LN; Lo HC
    Biol Psychiatry; 1987 Jul; 22(7):883-91. PubMed ID: 3607115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone suppression test response in major depression: stability across hospitalizations.
    Coryell W; Schlesser MA
    Psychiatry Res; 1983 Mar; 8(3):179-89. PubMed ID: 6574537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test.
    Beck-Friis J; Ljunggren JG; Thorén M; von Rosen D; Kjellman BF; Wetterberg L
    Psychoneuroendocrinology; 1985; 10(2):173-86. PubMed ID: 2994141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.